Expression of telomerase genes in thyroid carcinoma
- PMID: 12118320
Expression of telomerase genes in thyroid carcinoma
Abstract
Telomerase (T) is a ribonucleoprotein complex that includes the telomerase RNA component (hTR), telomerase associated protein (TP1) and the telomerase catalytic subunit (hTERT). Telomerase has been shown in stem cells and found to be activated in tumor tissues and immortalized cells. We wanted to test whether the expression of the telomerase complex subunits correlate with the enzyme activity in human thyroid tissue. Hence, we determined the expression of hTERT, hTR and TP1 mRNA by RT-PCR and compared the results to telomerase activity as detected by the telomeric repeat amplification protocol (TRAP) assay. Fifteen benign goiters (G), 11 follicular carcinomas (FTC) including 2 oncocytic follicular carcinomas (also called Hurthle cell carcinoma, oFTC), 12 papillary carcinomas (PTC) including 3 microcarcinomas (mPTC), and 12 undifferentiated anaplastic thyroid carcinomas (UTC) were investigated. Experienced pathologists performed histological and pTNM classification in each specimen. RT-PCR analysis revealed that TP1 was ubiquitously expressed in all G and carcinomas. hTR was expressed in 4 out of 15 G, in 2 out of 3 mPTC, in 5 out of 9 PTC, in 5 out of 9 FTC, in all oFTC and in 9 out of 12 UTC samples. Regarding all carcinomas, no statistically significant correlation was observed between hTR-expression and tumor stage, lymph node or distant metastasis. hTERT-expression was associated with malignancy and tumor stage. All mPTC and 13 out of 15 G did not express hTERT, whereas all samples of pT3-4 tumor stage of FTC, PTC, UTC and all oFTC were positive for hTERT. No telomerase activity could be detected in G. Telomerase activity in carcinoma was only measurable in tissues that expressed the catalytic subunit hTERT. Our data indicate that telomerase activity is up-regulated in neoplastic cells. In contrast to TP1 and hTR, hTERT and telomerase activity may be of help in identifying invasive tumors and may be additional markers for classification of benign goiter and malignant thyroid carcinoma.
Similar articles
-
Function of HSP90 and p23 in the telomerase complex of thyroid tumors.Pathol Res Pract. 2003;199(9):573-9. doi: 10.1078/0344-0338-00464. Pathol Res Pract. 2003. PMID: 14621192
-
Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.J Surg Oncol. 2004 May 1;86(2):99-104. doi: 10.1002/jso.20050. J Surg Oncol. 2004. PMID: 15112252
-
Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.Int J Oncol. 2002 Jan;20(1):15-21. Int J Oncol. 2002. PMID: 11743637
-
Telomerase, cervical cancer, and human papillomavirus.Clin Lab Med. 2000 Jun;20(2):369-82. Clin Lab Med. 2000. PMID: 10863645 Review.
-
Overview of the 2022 WHO Classification of Thyroid Neoplasms.Endocr Pathol. 2022 Mar;33(1):27-63. doi: 10.1007/s12022-022-09707-3. Epub 2022 Mar 14. Endocr Pathol. 2022. PMID: 35288841 Review.
Cited by
-
hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.Am J Pathol. 2003 Jun;162(6):1763-9. doi: 10.1016/S0002-9440(10)64311-8. Am J Pathol. 2003. PMID: 12759234 Free PMC article.
-
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules.Cytojournal. 2006 Apr 10;3:10. doi: 10.1186/1742-6413-3-10. Cytojournal. 2006. PMID: 16606457 Free PMC article.
-
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.J Clin Endocrinol Metab. 2014 May;99(5):E754-65. doi: 10.1210/jc.2013-3734. Epub 2014 Jan 29. J Clin Endocrinol Metab. 2014. PMID: 24476079 Free PMC article.
-
MicroRNA-22 enhances radiosensitivity in cervical cancer cell lines via direct inhibition of c-Myc binding protein, and the subsequent reduction in hTERT expression.Oncol Lett. 2020 Mar;19(3):2213-2222. doi: 10.3892/ol.2020.11344. Epub 2020 Jan 23. Oncol Lett. 2020. PMID: 32194719 Free PMC article.
-
Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas.Curr Genomics. 2011 Dec;12(8):609-17. doi: 10.2174/138920211798120853. Curr Genomics. 2011. PMID: 22654560 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical